Accelrys European Science Symposium Highlights Advanced Data Analysis and Predictive Science Symposium explores leading-edge software solutions that can transform scientific innovation
SAN DIEGO, June 11, 2012 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading scientific enterprise R&D software and services company, announced its first European Science Symposium with a focus on advancing scientific innovation through improved predictive science and data analysis. Taking place on June 20 at the Sheraton Brussels Hotel, this free event provides the opportunity for scientists to hear how academic and industry experts are addressing today's most difficult and important scientific challenges with advanced modeling, simulation and data analysis software solutions.
The Science Symposium includes speakers from Accelrys and ABB (Sweden), ETH (Zurich), EsbaTech (Switzerland), European Bioinformatics Institute and University of Dundee (UK), FMP and Fraunhofer IFAM (Germany), Universite de Mons (Belgium), Universidad de Navarra (Spain) and Institut de Recherches Servier, Discngine and Universite de Strasbourg (France).
"Recent years have seen a big shift in the focus of pharmaceutical drug research with an increased emphasis on more efficient innovation," said Dr. Hugues-Olivier Bertrand, Sr. Director of Modeling and Simulation at Accelrys. "Leveraging Accelrys' deep domain expertise in chemistry, biology and materials science, predictive science and informatics, the Science Symposium will explore new data analysis and modeling and simulation solutions that are accelerating the innovation cycle with compelling case studies drawn from the European research community."
The European Science Symposium offers three dedicated tracks focusing on:
- Scientific Data Analysis
This track focuses on the use of Pipeline Pilot and the scientific Component Collections that underpin Accelrys Enterprise Platform to solve problems spanning cheminformatics, bioinformatics (including Next Generation Sequencing), image analysis, statistical analysis and text analytics.
- Life Sciences Modeling and Simulation
This track focuses on the use of Accelrys Discovery Studio software in the discovery and development of macromolecule therapeutics and small molecule drugs. This track also features a demonstration of the upcoming Discovery Studio release along with case studies on the design and development of antibody drugs and lead optimization of small molecules.
- Materials Science Modeling and Simulation
This track focuses on the use of Accelrys Materials Studio software in the research and development of new materials and the optimization of existing materials and formulations. Case studies will cover topics such as polymer, formulation and catalysis modeling.
For registration and accommodation information including a detailed agenda with track and speaker descriptions, visit the European Science Symposium website.
About Accelrys, Inc.
Accelrys (NASDAQ: ACCL), a leading scientific enterprise R&D software and services company, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.
Accelrys solutions are used by more than 1,300 customers in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, Calif., Accelrys employs more than 200 full-time PhD scientists. For more information about Accelrys, visit www.accelrys.com.
SOURCE Accelrys, Inc.